References
- Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014;384:164-72
- US Food & Drug Administration Guidance for Industry: Pathological Complete Response in Neoadjuvant Treatment of High-Risk Early-Stage Breast Cancer: Use as an Endpoint to Support Accelerated Approval. October 2014. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm305501.pdf [Last accessed 28 November 2016]
Reference
- EFPIA and PhRMA joint principles for responsible clinical trial data sharing. July 2013. Available at: http://phrma.org/sites/default/files/pdf/PhRMAPrinciples ForResponsibleClinicalTrialDataSharing.pdf [Last accessed 2 December 2016]
References
- Duke CS, Poter JH. The ethics of data sharing and reuse in biology. BioScience 2013;63:438-9
- Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med 2015;163:461-4
- Redfearn S. Oncology, CNS lead therapeutic areas of opportunity. A CenterWatch Publication 2011;18:1-5
References
- Ann Intern Med 2015;163:461-4
- Scheckner et al. CMRO 2014;30(Suppl 1):S9
References
- Available at: https://www.elsevier.com/solutions/scopus/features/metrics [Last accessed 11 January 2017]
- Dresbeck R. SciVal. J Med Libr Assoc 2015;103:164-6
- Neylon C, Wu S. Article-level metrics and the evolution of scientific impact. PLoS Biol 2009
References
- Burns et al. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 2011;128:305-10
- Thomson Reuters in its Essential Science Indicators database from 2000 to 2010. Available at: https://www.timeshighereducation.com/news/citation-averages-2000-2010-by-fields-and-years/415643.article
Reference
- Fusaro G, Mathies R, Weigel A. Development of an authorship algorithm for industry sponsored publications. Presented at 10th Annual ISMPP Meeting. Arlington, VA, USA, 7–9 April 2014
Reference
- Novak SP et al. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry 2016: published online 4 August 2016
References
- ISMPP Issues and Actions Committee. The Rationale and Value of Medical Publications. Available at: http://www.ismpp.org/assets/docs/Inititives/advocacy/the_rationale_and_value_of_medical_publications.pdf [Last accessed 11 January 2017]
- Shnipper LE, Davidson NE, Wollins DS, et al. American Society of Clinical Oncology. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol 2015;33:2563-77
References
- Gattrell W, Hopewell S, Young K, et al. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study. BMJ Open 2016;6:
- Hays M, Andrews M, Wilson R, et al. Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis. BMJ Open 2016;6:e011082
Reference
- Giugliano RP, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369:2093–104